Radiation change versus recurrent astrocytoma: Diagnostic utility of the proliferation index?

Journal of Neuro-Oncology

Volumn 41, Issue 1, 1999, Pages 55-63

  Bigio, Eileen H ^a   Colvin, Sarah M ^a   Mickey, Bruce E ^a   White III, Charles L ^a   Rushing, Elisabeth J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Astrocytoma; Glioma; Ki 67; MIB 1; Proliferation marker; Radiation

Indexed keywords

MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CELL PROLIFERATION; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; GLIOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; RADIATION; RADIATION INJURY; RECURRENT DISEASE;

ADULT; AGED; ANTIGENS, NUCLEAR; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOSIS; HUMANS; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; RADIOTHERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032906254     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006112228001     Document Type: Article

References (24)

1. Bruner JM: Neuropathology of malignant gliomas. Semin Oncol 21: 126-138, 1994
2. Davis RL, Onda K, Shubuya M, Lamborn K, Hoshino T: Proliferation markers in gliomas: a comparison of BUDR, Ki-67, and MIB-1. J Neuro-Oncol 24: 9-12, 1995
3. Ellison DW, Steart PV, Gatter KC, Weller RO: Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 21: 352-361, 1995
4. Fischer AW, Holfelder H: Lokales Amyloid im Gehirn: Eine Spätfolge von Röntgenbestrahlungen. Deutsche Z Chir 227: 475-483, 1930
5. Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, Forsyth PA, Hayostek CJ: The MIB-1 LI in pilocytic and diffuse astrocytomas. [Abstract] J Neuropathol Exp Neurol 55(5): 605, 1996
6. Hsu DW, Louis DN, Efird JT, Hedley-Whyte ET: Use of Ki-67 (MIB-1) immunoreactivity in differentiating grade II and grade III gliomas. [Abstract] J Neuropathol Exp Neurol 55(5): 605, 1996
7. Hu Y, Hang Z, Ouyang M: Recurrent astrocytoma versus primary astrocytoma: a comparative study of morphological changes of 32 cases. Hua Hsi I Ko Ta Hsueh Hsueh Pao 25: 91-93, 1994
8. Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28: 818-822, 1990
9. Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengupta RP, Pearson ADJ: Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumors. Cancer 66: 373-385, 1992
10. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB-1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54, 1994
11. Kramer S: The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15: 318, 1968
12. Kramer S, Lee KF: Complications of radiation therapy: the central nervous system. Semin Roentgenol 9: 75-83, 1974
13. McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J: Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642, 1992
14. Oi S, Kolcunai T, Ihichi A, Matsumoto S, Raimondi AJ: Radiation-induced brain damage in children: histological analysis of sequential tissue changes in 34 autopsy cases. Neurol Med Chir 30: 36-42, 1990
15. Raskind R: Central nervous system damage after radiation therapy. Int Surg 48: 430-441, 1967
16. Raskind R, Bagshaw MA: Metastatische Karzinom simulierende Bestrahlungsnekrose des Halsmarkes. Radiobiol Radiother 7: 31-35, 1966
17. Sallinen PK, Haapasala HK, Visakorpi HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ: Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 174: 275-282, 1994
18. Satran R, Lapham LW, Kido DR: Late cerebral radionecrosis after conventional irradiation of cerebral tumors. Rev Neurol 140: 249-255, 1984
19. Schiffer D, Chio A, Giordana MT, Pezzulo T, Vigliani MC: Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study. Acta Neuropathol 85: 495-502, 1993
20. Tolly TL, Bruckman JE, Czarnecki DJ, Frazin LJ, Lewis HJ, Richards MJ, Adamkiewicz JJ Jr.: Early CT findings after interstitial radiation therapy for primary malignant brain tumors AJNR 9: 1177-1180, 1988
21. Vavruch L, Nordenskjold B, Carstensen J, Enestrom S: DNA ploidy and S-phase in recurrent astrocytomas: a retrospective study by flow cytometry of deparaffinized specimens. J Neuro-Oncol 30: 37-45, 1996
22. Wakimoto H, Aoyagi M, Nakayama T, Nagashima G, Yamamoto S, Tamaki M, Hirakawa K: Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77: 373-380, 1996
23. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G, Kiessling M, Cremer T: Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13: 983-994, 1996
24. Yamashita J, Handa H, Yumitori K, Abe M: Reversible delayed radiation effect on the brain after radiotherapy of malignant astrocytoma. Surg Neurol 13: 413-417, 1980